NEKTAR THERAPEUTICS financial data

Symbol
NKTR on Nasdaq
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355% % -34%
Quick Ratio 13% % -62%
Debt-to-equity 690% % 152%
Return On Equity -357% % -105%
Return On Assets -45% % 3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20,341,589 shares -89%
Common Stock, Shares, Outstanding 19,652,513 shares -89%
Entity Public Float $226,000,000 USD 107%
Common Stock, Value, Issued $2,000 USD -89%
Weighted Average Number of Shares Outstanding, Basic 18,946,559 shares 36%
Weighted Average Number of Shares Outstanding, Diluted 18,946,559 shares 36%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $62,600,000 USD -33%
Research and Development Expense $116,363,000 USD -4.7%
General and Administrative Expense $74,623,000 USD -3%
Costs and Expenses $160,689,000 USD -35%
Operating Income (Loss) $98,089,000 USD 36%
Nonoperating Income (Expense) $15,694,000 USD -2.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $119,200,000 USD 57%
Income Tax Expense (Benefit) $428,000 USD -4656%
Net Income (Loss) Attributable to Parent $120,736,000 USD 28%
Earnings Per Share, Basic 0 USD/shares 30%
Earnings Per Share, Diluted 0 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $41,032,000 USD 36%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Inventory, Net $0 USD -100%
Other Assets, Current $11,149,000 USD 25%
Assets, Current $281,357,000 USD -1.8%
Property, Plant and Equipment, Net $2,826,000 USD -22%
Operating Lease, Right-of-Use Asset $7,171,000 USD -19%
Other Assets, Noncurrent $5,156,000 USD 14%
Assets $301,347,000 USD -2.1%
Accounts Payable, Current $15,563,000 USD 81%
Employee-related Liabilities, Current $8,606,000 USD 23%
Accrued Liabilities, Current $28,594,000 USD -12%
Liabilities, Current $66,340,000 USD -1.8%
Operating Lease, Liability, Noncurrent $69,732,000 USD -20%
Other Liabilities, Noncurrent $5,025,000 USD -27%
Liabilities $216,261,000 USD -17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $56,000 USD -84%
Retained Earnings (Accumulated Deficit) $3,724,207,000 USD -3.4%
Stockholders' Equity Attributable to Parent $85,086,000 USD 74%
Liabilities and Equity $301,347,000 USD -2.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $49,053,000 USD -2.4%
Net Cash Provided by (Used in) Financing Activities $42,003,000 USD
Net Cash Provided by (Used in) Investing Activities $43,689,000 USD 127%
Common Stock, Shares Authorized 390,000,000 shares 30%
Common Stock, Shares, Issued 19,652,513 shares -90%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,358,000 USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41,032,000 USD 36%
Deferred Tax Assets, Valuation Allowance $859,084,000 USD 0.53%
Deferred Tax Assets, Gross $862,462,000 USD 0.45%
Operating Lease, Liability $102,564,000 USD -13%
Payments to Acquire Property, Plant, and Equipment $157,000 USD -64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $121,035,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid $118,820,000 USD -15%
Operating Lease, Liability, Current $22,183,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $22,958,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $20,450,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) $38,000 USD 98%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16,256,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Three $23,682,000 USD 3.2%
Deferred Tax Assets, Operating Loss Carryforwards $587,528,000 USD 2.2%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $135,672,000 USD 7.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four $24,427,000 USD 3.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $3,378,000 USD -17%
Share-based Payment Arrangement, Expense $15,259,000 USD -37%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%